Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe history now shows a new revision entry, v3.3.2, replacing v3.3.1.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision entry (v3.3.1) was added and an earlier revision (v3.2.0) was removed. This update affects version-tracking information in the page history and does not alter study data or page functionality.SummaryDifference0.1%

- Check20 days agoChange DetectedDeleted the notice about a lapse in government funding that warned information may not be up to date and directed users to opm.gov for operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check34 days agoChange DetectedNew versions appear in the record history up to 2025-05-13, and an IPDSharing field is now noted in the study record; the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference11%

- Check70 days agoChange DetectedUpdate: version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.3%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.